Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a protein and a group of small ribonucleic acids (sRNAs) in...
Researchers at the Helmholtz Centre for Infection Research (HZI) have developed a promising new vaccine technology. Their studies to date show that just one dose of vaccine leads to effective and long-lasting immune...
The interdisciplinary project DEFENDER is developing innovative approaches to combat (re-)emerging viruses. The project, coordinated by the Leibniz Institute of Virology (LIV), is being funded with around eight 9.6...
A research team from the Helmholtz Institute for One Health (HIOH) has investigated the distribution and characteristics of multidrug-resistant bacteria in the Baltic Sea. The findings prove that resistant pathogens...
Global migration has increased in recent decades due to war, conflict, persecutions, and natural disasters, but also secondary to increased opportunities related to work or study. A group of international experts that...
Microorganisms produce a wide variety of natural products that can be used as active ingredients to treat diseases such as infections or cancer. The blueprints for these molecules can be found in the microbes' genes,...
13.12.2024
Emerging Diseases - A challenge for research, medicine and society
In April 2024, the Helmholtz Centre for Infection Research (HZI) completely revamped its website together with the digital agency +Pluswerk. The aim of this relaunch was to present the HZI and its scientific work to the...
09.12.2024
Dr Lina Herhaus
Dr Lina Herhaus Research Group Leader +49 531 6181-3065 E-Mail Lina Herhaus is an accomplished scientist specializing in biochemistry, cell signaling, and immune research. Since October 2024, she has lead the "Immune Signaling"…
